Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Large Scale Clinical Trial Testing the Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic Congestive Heart Failure

Trial Profile

A Large Scale Clinical Trial Testing the Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic Congestive Heart Failure

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rosuvastatin (Primary) ; Omega-3-acid ethyl esters
  • Indications Chronic heart failure; Heart failure
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms GISSI-HF
  • Most Recent Events

    • 20 Nov 2013 Results for the prognostic impact of metabolic syndrome presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 20 Nov 2013 Pooled results for competing risks for fatal/non-fatal myocardial infarction (MI), fatal/non-fatal stroke, other CV death, and non-CV death presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 17 Nov 2013 Results of an analysis investigating the effect of bodyweight changes in outcomes presented at the 86th Annual Scientific Sessions of the American Heart Association.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top